Miller Ann Calby 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 17, 2022
Insider Transaction Report
Form 4
Miller Ann Calby
Director
Transactions
- Exercise/Conversion
Common Stock
2022-05-13+18,000→ 47,534 total - Exercise/Conversion
Restricted Stock Unit
2022-05-13−18,000→ 0 total→ Common Stock (18,000 underlying) - Award
Restricted Stock Unit
2022-05-16+19,000→ 19,000 total→ Common Stock (19,000 underlying) - Award
Common Stock Options
2022-05-16+28,000→ 28,000 totalExercise: $1.89Exp: 2032-05-16→ Common Stock (28,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
- [F3]This grant was made pursuant to the issuer's non-employee director compensation policy.
- [F4]Options to vest 100% on May 16, 2023.